Fig. 4

Time to the first complaint. Solid lines show the cumulative incidence of visiting the general practitioner or emergency ward with common complaints for up to 90 days after a (hypothetical) date of the third dose of mRNA vaccines, per 100,000 individuals for individuals under the age of 45. Red curve shows individuals with three doses (three-dose group), and blue curve shows the control group consisting of individuals without three doses. Shaded areas show 95% confidence intervals. Dashed lines show the cumulative incidence of competing risks. Competing risk includes death and hospitalization. Dashed vertical line represents day 7, prior to which no vaccine effectiveness can be expected